Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Immuno-Cell Therapy market report explains the definition, types, applications, major countries, and major players of the Immuno-Cell Therapy market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Seta Clinic Group
Beroni Group
Vericel Corporation
Takeda
Fate Therapeutics
Novartis
JCR Pharmaceuticals
Guanhao Biotech
MEDINET Co
Gilead Sciences
Golden Meditech
Fujifilm Cellular Dynamics
SBI Holdings
Osiris
Beike Biotechnology
Oxford BioTherapeutics
Erytech
By Type:
Passive Immune (NK
LAK etc)
Active Immune
By End-User:
Oncology
Cardiovascular Disease (CVD)
Orthopedic
Wound Healing
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Immuno-Cell Therapy Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Immuno-Cell Therapy Outlook to 2028- Original Forecasts
-
2.2 Immuno-Cell Therapy Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Immuno-Cell Therapy Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Immuno-Cell Therapy Market- Recent Developments
-
6.1 Immuno-Cell Therapy Market News and Developments
-
6.2 Immuno-Cell Therapy Market Deals Landscape
7 Immuno-Cell Therapy Raw Materials and Cost Structure Analysis
-
7.1 Immuno-Cell Therapy Key Raw Materials
-
7.2 Immuno-Cell Therapy Price Trend of Key Raw Materials
-
7.3 Immuno-Cell Therapy Key Suppliers of Raw Materials
-
7.4 Immuno-Cell Therapy Market Concentration Rate of Raw Materials
-
7.5 Immuno-Cell Therapy Cost Structure Analysis
-
7.5.1 Immuno-Cell Therapy Raw Materials Analysis
-
7.5.2 Immuno-Cell Therapy Labor Cost Analysis
-
7.5.3 Immuno-Cell Therapy Manufacturing Expenses Analysis
8 Global Immuno-Cell Therapy Import and Export Analysis (Top 10 Countries)
-
8.1 Global Immuno-Cell Therapy Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Immuno-Cell Therapy Export by Region (Top 10 Countries) (2017-2028)
9 Global Immuno-Cell Therapy Market Outlook by Types and Applications to 2022
-
9.1 Global Immuno-Cell Therapy Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Passive Immune (NK Consumption and Growth Rate (2017-2022)
-
9.1.2 Global LAK etc) Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Active Immune Consumption and Growth Rate (2017-2022)
-
9.2 Global Immuno-Cell Therapy Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Oncology Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cardiovascular Disease (CVD) Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Orthopedic Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Wound Healing Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Immuno-Cell Therapy Market Analysis and Outlook till 2022
-
10.1 Global Immuno-Cell Therapy Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Immuno-Cell Therapy Consumption (2017-2022)
-
10.2.2 Canada Immuno-Cell Therapy Consumption (2017-2022)
-
10.2.3 Mexico Immuno-Cell Therapy Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Immuno-Cell Therapy Consumption (2017-2022)
-
10.3.2 UK Immuno-Cell Therapy Consumption (2017-2022)
-
10.3.3 Spain Immuno-Cell Therapy Consumption (2017-2022)
-
10.3.4 Belgium Immuno-Cell Therapy Consumption (2017-2022)
-
10.3.5 France Immuno-Cell Therapy Consumption (2017-2022)
-
10.3.6 Italy Immuno-Cell Therapy Consumption (2017-2022)
-
10.3.7 Denmark Immuno-Cell Therapy Consumption (2017-2022)
-
10.3.8 Finland Immuno-Cell Therapy Consumption (2017-2022)
-
10.3.9 Norway Immuno-Cell Therapy Consumption (2017-2022)
-
10.3.10 Sweden Immuno-Cell Therapy Consumption (2017-2022)
-
10.3.11 Poland Immuno-Cell Therapy Consumption (2017-2022)
-
10.3.12 Russia Immuno-Cell Therapy Consumption (2017-2022)
-
10.3.13 Turkey Immuno-Cell Therapy Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Immuno-Cell Therapy Consumption (2017-2022)
-
10.4.2 Japan Immuno-Cell Therapy Consumption (2017-2022)
-
10.4.3 India Immuno-Cell Therapy Consumption (2017-2022)
-
10.4.4 South Korea Immuno-Cell Therapy Consumption (2017-2022)
-
10.4.5 Pakistan Immuno-Cell Therapy Consumption (2017-2022)
-
10.4.6 Bangladesh Immuno-Cell Therapy Consumption (2017-2022)
-
10.4.7 Indonesia Immuno-Cell Therapy Consumption (2017-2022)
-
10.4.8 Thailand Immuno-Cell Therapy Consumption (2017-2022)
-
10.4.9 Singapore Immuno-Cell Therapy Consumption (2017-2022)
-
10.4.10 Malaysia Immuno-Cell Therapy Consumption (2017-2022)
-
10.4.11 Philippines Immuno-Cell Therapy Consumption (2017-2022)
-
10.4.12 Vietnam Immuno-Cell Therapy Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Immuno-Cell Therapy Consumption (2017-2022)
-
10.5.2 Colombia Immuno-Cell Therapy Consumption (2017-2022)
-
10.5.3 Chile Immuno-Cell Therapy Consumption (2017-2022)
-
10.5.4 Argentina Immuno-Cell Therapy Consumption (2017-2022)
-
10.5.5 Venezuela Immuno-Cell Therapy Consumption (2017-2022)
-
10.5.6 Peru Immuno-Cell Therapy Consumption (2017-2022)
-
10.5.7 Puerto Rico Immuno-Cell Therapy Consumption (2017-2022)
-
10.5.8 Ecuador Immuno-Cell Therapy Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Immuno-Cell Therapy Consumption (2017-2022)
-
10.6.2 Kuwait Immuno-Cell Therapy Consumption (2017-2022)
-
10.6.3 Oman Immuno-Cell Therapy Consumption (2017-2022)
-
10.6.4 Qatar Immuno-Cell Therapy Consumption (2017-2022)
-
10.6.5 Saudi Arabia Immuno-Cell Therapy Consumption (2017-2022)
-
10.6.6 United Arab Emirates Immuno-Cell Therapy Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Immuno-Cell Therapy Consumption (2017-2022)
-
10.7.2 South Africa Immuno-Cell Therapy Consumption (2017-2022)
-
10.7.3 Egypt Immuno-Cell Therapy Consumption (2017-2022)
-
10.7.4 Algeria Immuno-Cell Therapy Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Immuno-Cell Therapy Consumption (2017-2022)
-
10.8.2 New Zealand Immuno-Cell Therapy Consumption (2017-2022)
11 Global Immuno-Cell Therapy Competitive Analysis
-
11.1 Seta Clinic Group
-
11.1.1 Seta Clinic Group Company Details
-
11.1.2 Seta Clinic Group Immuno-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Seta Clinic Group Immuno-Cell Therapy Main Business and Markets Served
-
11.1.4 Seta Clinic Group Immuno-Cell Therapy Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Beroni Group
-
11.2.1 Beroni Group Company Details
-
11.2.2 Beroni Group Immuno-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Beroni Group Immuno-Cell Therapy Main Business and Markets Served
-
11.2.4 Beroni Group Immuno-Cell Therapy Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Vericel Corporation
-
11.3.1 Vericel Corporation Company Details
-
11.3.2 Vericel Corporation Immuno-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Vericel Corporation Immuno-Cell Therapy Main Business and Markets Served
-
11.3.4 Vericel Corporation Immuno-Cell Therapy Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Takeda
-
11.4.1 Takeda Company Details
-
11.4.2 Takeda Immuno-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Takeda Immuno-Cell Therapy Main Business and Markets Served
-
11.4.4 Takeda Immuno-Cell Therapy Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Fate Therapeutics
-
11.5.1 Fate Therapeutics Company Details
-
11.5.2 Fate Therapeutics Immuno-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Fate Therapeutics Immuno-Cell Therapy Main Business and Markets Served
-
11.5.4 Fate Therapeutics Immuno-Cell Therapy Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Novartis
-
11.6.1 Novartis Company Details
-
11.6.2 Novartis Immuno-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Novartis Immuno-Cell Therapy Main Business and Markets Served
-
11.6.4 Novartis Immuno-Cell Therapy Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 JCR Pharmaceuticals
-
11.7.1 JCR Pharmaceuticals Company Details
-
11.7.2 JCR Pharmaceuticals Immuno-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 JCR Pharmaceuticals Immuno-Cell Therapy Main Business and Markets Served
-
11.7.4 JCR Pharmaceuticals Immuno-Cell Therapy Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Guanhao Biotech
-
11.8.1 Guanhao Biotech Company Details
-
11.8.2 Guanhao Biotech Immuno-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Guanhao Biotech Immuno-Cell Therapy Main Business and Markets Served
-
11.8.4 Guanhao Biotech Immuno-Cell Therapy Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 MEDINET Co
-
11.9.1 MEDINET Co Company Details
-
11.9.2 MEDINET Co Immuno-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 MEDINET Co Immuno-Cell Therapy Main Business and Markets Served
-
11.9.4 MEDINET Co Immuno-Cell Therapy Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Gilead Sciences
-
11.10.1 Gilead Sciences Company Details
-
11.10.2 Gilead Sciences Immuno-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Gilead Sciences Immuno-Cell Therapy Main Business and Markets Served
-
11.10.4 Gilead Sciences Immuno-Cell Therapy Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Golden Meditech
-
11.11.1 Golden Meditech Company Details
-
11.11.2 Golden Meditech Immuno-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Golden Meditech Immuno-Cell Therapy Main Business and Markets Served
-
11.11.4 Golden Meditech Immuno-Cell Therapy Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Fujifilm Cellular Dynamics
-
11.12.1 Fujifilm Cellular Dynamics Company Details
-
11.12.2 Fujifilm Cellular Dynamics Immuno-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Fujifilm Cellular Dynamics Immuno-Cell Therapy Main Business and Markets Served
-
11.12.4 Fujifilm Cellular Dynamics Immuno-Cell Therapy Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 SBI Holdings
-
11.13.1 SBI Holdings Company Details
-
11.13.2 SBI Holdings Immuno-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 SBI Holdings Immuno-Cell Therapy Main Business and Markets Served
-
11.13.4 SBI Holdings Immuno-Cell Therapy Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Osiris
-
11.14.1 Osiris Company Details
-
11.14.2 Osiris Immuno-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Osiris Immuno-Cell Therapy Main Business and Markets Served
-
11.14.4 Osiris Immuno-Cell Therapy Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Beike Biotechnology
-
11.15.1 Beike Biotechnology Company Details
-
11.15.2 Beike Biotechnology Immuno-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Beike Biotechnology Immuno-Cell Therapy Main Business and Markets Served
-
11.15.4 Beike Biotechnology Immuno-Cell Therapy Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 Oxford BioTherapeutics
-
11.16.1 Oxford BioTherapeutics Company Details
-
11.16.2 Oxford BioTherapeutics Immuno-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 Oxford BioTherapeutics Immuno-Cell Therapy Main Business and Markets Served
-
11.16.4 Oxford BioTherapeutics Immuno-Cell Therapy Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 Erytech
-
11.17.1 Erytech Company Details
-
11.17.2 Erytech Immuno-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 Erytech Immuno-Cell Therapy Main Business and Markets Served
-
11.17.4 Erytech Immuno-Cell Therapy Product Portfolio
-
11.17.5 Recent Research and Development Strategies
12 Global Immuno-Cell Therapy Market Outlook by Types and Applications to 2028
-
12.1 Global Immuno-Cell Therapy Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Passive Immune (NK Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global LAK etc) Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Active Immune Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Immuno-Cell Therapy Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Cardiovascular Disease (CVD) Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Orthopedic Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Wound Healing Consumption Forecast and Growth Rate (2022-2028)
-
12.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Immuno-Cell Therapy Market Analysis and Outlook to 2028
-
13.1 Global Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.2.2 Canada Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.2.3 Mexico Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.3.2 UK Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.3.3 Spain Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.3.4 Belgium Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.3.5 France Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.3.6 Italy Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.3.7 Denmark Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.3.8 Finland Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.3.9 Norway Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.3.10 Sweden Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.3.11 Poland Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.3.12 Russia Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.3.13 Turkey Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.4.2 Japan Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.4.3 India Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.4.4 South Korea Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.4.8 Thailand Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.4.9 Singapore Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.4.11 Philippines Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.5.2 Colombia Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.5.3 Chile Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.5.4 Argentina Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.5.6 Peru Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.6.3 Oman Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.6.4 Qatar Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.7.2 South Africa Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.7.3 Egypt Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.7.4 Algeria Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Immuno-Cell Therapy Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Immuno-Cell Therapy Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Immuno-Cell Therapy
-
Figure of Immuno-Cell Therapy Picture
-
Table Global Immuno-Cell Therapy Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Immuno-Cell Therapy Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Passive Immune (NK Consumption and Growth Rate (2017-2022)
-
Figure Global LAK etc) Consumption and Growth Rate (2017-2022)
-
Figure Global Active Immune Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiovascular Disease (CVD) Consumption and Growth Rate (2017-2022)
-
Figure Global Orthopedic Consumption and Growth Rate (2017-2022)
-
Figure Global Wound Healing Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Immuno-Cell Therapy Consumption by Country (2017-2022)
-
Table North America Immuno-Cell Therapy Consumption by Country (2017-2022)
-
Figure United States Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Canada Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Mexico Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Table Europe Immuno-Cell Therapy Consumption by Country (2017-2022)
-
Figure Germany Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure UK Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Spain Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Belgium Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure France Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Italy Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Denmark Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Finland Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Norway Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Sweden Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Poland Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Russia Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Turkey Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Table APAC Immuno-Cell Therapy Consumption by Country (2017-2022)
-
Figure China Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Japan Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure India Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure South Korea Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Thailand Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Singapore Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Philippines Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Table South America Immuno-Cell Therapy Consumption by Country (2017-2022)
-
Figure Brazil Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Colombia Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Chile Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Argentina Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Peru Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Table GCC Immuno-Cell Therapy Consumption by Country (2017-2022)
-
Figure Bahrain Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Oman Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Qatar Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Table Africa Immuno-Cell Therapy Consumption by Country (2017-2022)
-
Figure Nigeria Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure South Africa Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Egypt Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Algeria Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Table Oceania Immuno-Cell Therapy Consumption by Country (2017-2022)
-
Figure Australia Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Immuno-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Table Seta Clinic Group Company Details
-
Table Seta Clinic Group Immuno-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Seta Clinic Group Immuno-Cell Therapy Main Business and Markets Served
-
Table Seta Clinic Group Immuno-Cell Therapy Product Portfolio
-
Table Beroni Group Company Details
-
Table Beroni Group Immuno-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Beroni Group Immuno-Cell Therapy Main Business and Markets Served
-
Table Beroni Group Immuno-Cell Therapy Product Portfolio
-
Table Vericel Corporation Company Details
-
Table Vericel Corporation Immuno-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vericel Corporation Immuno-Cell Therapy Main Business and Markets Served
-
Table Vericel Corporation Immuno-Cell Therapy Product Portfolio
-
Table Takeda Company Details
-
Table Takeda Immuno-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Immuno-Cell Therapy Main Business and Markets Served
-
Table Takeda Immuno-Cell Therapy Product Portfolio
-
Table Fate Therapeutics Company Details
-
Table Fate Therapeutics Immuno-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Fate Therapeutics Immuno-Cell Therapy Main Business and Markets Served
-
Table Fate Therapeutics Immuno-Cell Therapy Product Portfolio
-
Table Novartis Company Details
-
Table Novartis Immuno-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Immuno-Cell Therapy Main Business and Markets Served
-
Table Novartis Immuno-Cell Therapy Product Portfolio
-
Table JCR Pharmaceuticals Company Details
-
Table JCR Pharmaceuticals Immuno-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table JCR Pharmaceuticals Immuno-Cell Therapy Main Business and Markets Served
-
Table JCR Pharmaceuticals Immuno-Cell Therapy Product Portfolio
-
Table Guanhao Biotech Company Details
-
Table Guanhao Biotech Immuno-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Guanhao Biotech Immuno-Cell Therapy Main Business and Markets Served
-
Table Guanhao Biotech Immuno-Cell Therapy Product Portfolio
-
Table MEDINET Co Company Details
-
Table MEDINET Co Immuno-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table MEDINET Co Immuno-Cell Therapy Main Business and Markets Served
-
Table MEDINET Co Immuno-Cell Therapy Product Portfolio
-
Table Gilead Sciences Company Details
-
Table Gilead Sciences Immuno-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Sciences Immuno-Cell Therapy Main Business and Markets Served
-
Table Gilead Sciences Immuno-Cell Therapy Product Portfolio
-
Table Golden Meditech Company Details
-
Table Golden Meditech Immuno-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Golden Meditech Immuno-Cell Therapy Main Business and Markets Served
-
Table Golden Meditech Immuno-Cell Therapy Product Portfolio
-
Table Fujifilm Cellular Dynamics Company Details
-
Table Fujifilm Cellular Dynamics Immuno-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Fujifilm Cellular Dynamics Immuno-Cell Therapy Main Business and Markets Served
-
Table Fujifilm Cellular Dynamics Immuno-Cell Therapy Product Portfolio
-
Table SBI Holdings Company Details
-
Table SBI Holdings Immuno-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table SBI Holdings Immuno-Cell Therapy Main Business and Markets Served
-
Table SBI Holdings Immuno-Cell Therapy Product Portfolio
-
Table Osiris Company Details
-
Table Osiris Immuno-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Osiris Immuno-Cell Therapy Main Business and Markets Served
-
Table Osiris Immuno-Cell Therapy Product Portfolio
-
Table Beike Biotechnology Company Details
-
Table Beike Biotechnology Immuno-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Beike Biotechnology Immuno-Cell Therapy Main Business and Markets Served
-
Table Beike Biotechnology Immuno-Cell Therapy Product Portfolio
-
Table Oxford BioTherapeutics Company Details
-
Table Oxford BioTherapeutics Immuno-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Oxford BioTherapeutics Immuno-Cell Therapy Main Business and Markets Served
-
Table Oxford BioTherapeutics Immuno-Cell Therapy Product Portfolio
-
Table Erytech Company Details
-
Table Erytech Immuno-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Erytech Immuno-Cell Therapy Main Business and Markets Served
-
Table Erytech Immuno-Cell Therapy Product Portfolio
-
Figure Global Passive Immune (NK Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global LAK etc) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Active Immune Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiovascular Disease (CVD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Orthopedic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Wound Healing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immuno-Cell Therapy Consumption Forecast by Country (2022-2028)
-
Table North America Immuno-Cell Therapy Consumption Forecast by Country (2022-2028)
-
Figure United States Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Immuno-Cell Therapy Consumption Forecast by Country (2022-2028)
-
Figure Germany Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Immuno-Cell Therapy Consumption Forecast by Country (2022-2028)
-
Figure China Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Immuno-Cell Therapy Consumption Forecast by Country (2022-2028)
-
Figure Brazil Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Immuno-Cell Therapy Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Immuno-Cell Therapy Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Immuno-Cell Therapy Consumption Forecast by Country (2022-2028)
-
Figure Australia Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Immuno-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
